PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-16.40%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-29.55%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-62.46%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-62.46%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-63.67%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-65.79%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-64.86%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
2.06%
Share change of 2.06% while ON is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
-12.19%
Reduced diluted shares while ON is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-2.02%
Dividend reduction while ON stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-81.83%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-145.60%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
9.31%
Positive 10Y revenue/share CAGR while ON is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
-19.03%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
1.93%
Positive 3Y CAGR while ON is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
72.96%
Positive long-term OCF/share growth while ON is negative. John Neff would see a structural advantage in sustained cash generation.
241.61%
Positive OCF/share growth while ON is negative. John Neff might see a comparative advantage in operational cash viability.
333.18%
Positive 3Y OCF/share CAGR while ON is negative. John Neff might see a big short-term edge in operational efficiency.
403.33%
Positive 10Y CAGR while ON is negative. John Neff might see a substantial advantage in bottom-line trajectory.
20.89%
Positive 5Y CAGR while ON is negative. John Neff might view this as a strong mid-term relative advantage.
1743.73%
Positive short-term CAGR while ON is negative. John Neff would see a clear advantage in near-term profit trajectory.
305.24%
Below 50% of ON's 4838.34%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
163.29%
Below 50% of ON's 4838.34%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
91.82%
Below 50% of ON's 4838.34%. Michael Burry suspects a serious short-term disadvantage in building book value.
5.40%
Dividend/share CAGR of 5.40% while ON is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
-0.94%
Negative 5Y dividend/share CAGR while ON stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-1.13%
Negative near-term dividend growth while ON invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-11.62%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-4.30%
Inventory is declining while ON stands at 7.01%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-2.70%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
1.20%
Positive BV/share change while ON is negative. John Neff sees a clear edge over a competitor losing equity.
-6.60%
We’re deleveraging while ON stands at 0.31%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
1.13%
R&D dropping or stable vs. ON's 11.17%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-13.22%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.